Why does the world need another rotavirus vaccine?

References

• AdamsWRKraftLMEpizootic diarrhea of infant mice: indentification of the etiologic agentScience19631413596014011026
   PubMed Web of Science ®Google Scholar
• AgnelloDHerveCALavauxAIntrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in miceJ Virol20068038233216571799
   PubMed Web of Science ®Google Scholar
• AijazSGowdaKJagannathHVEpidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysisArch Virol1996141715268645107
   PubMed Web of Science ®Google Scholar
• BanerjeeIGladstoneBPLe FevreAMNeonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South IndiaJ Infect Dis20071956253217262703
   PubMed Web of Science ®Google Scholar
• BarnesGLLundJSMitchellSVEarly phase II trial of human rotavirus vaccine candidate RV3Vaccine2002202950612126907
   PubMed Web of Science ®Google Scholar
• BernsteinDISackDARothsteinEEfficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trialLancet19993542879010440305
   PubMed Web of Science ®Google Scholar
• BernsteinDISmithVESanderDSEvaluation of WC3 rotavirus vaccine and correlates of protection in healthy infantsJ Infect Dis19901621055622172394
   PubMed Web of Science ®Google Scholar
• BernsteinDISmithVESherwoodJRSafety and immunogenicity of live, attenuated human rotavirus vaccine 89-12Vaccine19981638179607059
   PubMed Web of Science ®Google Scholar
• Bertolotti-CiarletACiarletMCrawfordSEImmunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to miceVaccine200321388590012922123
   PubMed Web of Science ®Google Scholar
• BhanMKLewJFSazawalSProtection conferred by neonatal rotavirus infection against subsequent rotavirus diarrheaJ Infect Dis199316828278393054
   PubMed Web of Science ®Google Scholar
• BhandariNSharmaPGlassRISafety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trialVaccine20062458172316735085
   PubMed Web of Science ®Google Scholar
• BishopRFDavidsonGPHolmesIHVirus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritisLancet19732128134127639
   PubMed Web of Science ®Google Scholar
• BluttSEWarfieldKLEstesMKImmunity to rotavirus requires CD4+ T cells9th dsRNA Virus Symposium2006Cape Town, South Africa
   Google Scholar
• BridgerJCDetection by electron microscopy of caliciviruses, astroviruses and rotavirus-like particles in the faeces of piglets with diarrhoeaVet Rec198010753236258286
   PubMed Web of Science ®Google Scholar
• BridgerJCOldhamGAvirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibodyJ Gen Virol1987682311172821172
   PubMed Web of Science ®Google Scholar
• BurnsJWSiadat-PajouhMKrishnaneyAAProtective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activityScience199627210478600516
   PubMed Web of Science ®Google Scholar
• CheeverFSMuellerJHEpidemic kiarrheal disease of suckling mice I. Manifestations, epidemiology, and attempts to transmit the diseaseJ Exp Med19478540516
   PubMed Web of Science ®Google Scholar
• ChibaSYokoyamaTNakataSProtective effect of naturally acquired homotypic and heterotypic rotavirus antibodiesLancet19862417212874413
   PubMed Web of Science ®Google Scholar
• ChoiAHBasuMMcNealMMAntibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 proteinJ Virol19997375748110438847
   PubMed Web of Science ®Google Scholar
• ChoiAHMcNealMMBasuMIntranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotavirusesVaccine20022033102112213401
   PubMed Web of Science ®Google Scholar
• CiarletMCrawfordSEBaroneCSubunit rotavirus vaccine administered parenterally to rabbits induces active protective immunityJ Virol1998729233469765471
   PubMed Web of Science ®Google Scholar
• ClarkHFBernsteinDIDennehyPHSafety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infantsJ Pediatr20041441849014760258
   PubMed Web of Science ®Google Scholar
• ClarkHFBorianFEBellLMProtective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus seasonJ Infect Dis1988158570872842405
   PubMed Web of Science ®Google Scholar
• ClarkHFBorianFEPlotkinSAImmune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3J Infect Dis199016110991042161038
   PubMed Web of Science ®Google Scholar
• ClarkHFOffitPAPlotkinSAThe new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortantsPediatr Infect Dis J2006255778316804425
   PubMed Web of Science ®Google Scholar
• ClemensJDWardRLRaoMRSeroepidemiologic evaluation of antibodies to rotavirus as correlates of the risk of clinically significant rotavirus diarrhea in rural BangladeshJ Infect Dis199216516151309372
   PubMed Web of Science ®Google Scholar
• Clements-MannMLMakheneMKMrukowiczJSafety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infantsVaccine19991727152510418923
   PubMed Web of Science ®Google Scholar
• ConnerMECrawfordSEBaroneCRotavirus vaccine administered parenterally induces protective immunityJ Virol1993676633418411366
   PubMed Web of Science ®Google Scholar
• CorthesyBBenureauYPerrierCRotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusionJ Virol20068010692916956954
   PubMed Web of Science ®Google Scholar
• CoulsonBSGrimwoodKHudsonILRole of coproantibody in clinical protection of children during reinfection with rotavirusJ Clin Microbiol1992301678841321167
   PubMed Web of Science ®Google Scholar
• CrawfordSELabbeMCohenJCharacterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cellsJ Virol1994685945528057471
   PubMed Web of Science ®Google Scholar
• DasBKGentschJRCicirelloHGCharacterization of rotavirus strains from newborns in New Delhi, IndiaJ Clin Microbiol199432182027929782
   PubMed Web of Science ®Google Scholar
• DasMDunnSJWoodeGNBoth surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirusVirology199319437498386881
   PubMed Web of Science ®Google Scholar
• de ZoysaIFeachemRGInterventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunizationBull World Health Organ198563569833876173
   PubMed Web of Science ®Google Scholar
• DeMolPZissisGTubzlerJPFailure of live attenuated oral rotavirus vaccineLancet19862108
   Web of Science ®Google Scholar
• DennehyPHBradyRCHalperinSAComparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccinePediatr Infect Dis J200524481815933555
   PubMed Web of Science ®Google Scholar
• DharakulTRottLGreenbergHBRecovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytesJ Virol1990644375821974652
   PubMed Web of Science ®Google Scholar
• DunnSJWardRLMcNealMMIdentification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutionsVirology19931973974047692670
   PubMed Web of Science ®Google Scholar
• EstesMKKapikainAZKnipeDMHowleyPMRotavirusesFields Virology2007PhiladelphiaLippincott, Williams and Wilkins191774
   Google Scholar
• EstesMKMasonBBCrawfordSCloning and nucleotide sequence of the simian rotavirus gene 6 that codes for the major inner capsid proteinNucleic Acids Res1984121875876322125
   PubMed Web of Science ®Google Scholar
• FengNBurnsJWBracyLComparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirusJ Virol1994687766737966566
   PubMed Web of Science ®Google Scholar
• FengNLawtonJAGilbertJInhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAbJ Clin Invest200210912031311994409
   PubMed Web of Science ®Google Scholar
• FlewettTHBrydenASDaviesHRelation between viruses from acute gastroenteritis of children and newborn calvesLancet197426134137164
   PubMed Web of Science ®Google Scholar
• FloresJKapikianAZWoodrowGCLevineMMVaccines against rotavirusNew Generation Vaccines1990New YorkMarcel Dekker76588
   Google Scholar
• FloresJPerez-SchaelIGonzalezMProtection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infantsLancet1987188242882289
   PubMed Web of Science ®Google Scholar
• FrancoMAGreenbergHBRole of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in miceJ Virol199569780067494291
   PubMed Web of Science ®Google Scholar
• FrancoMALefevrePWillemsPIdentification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteinsJ Gen Virol199475589967510328
   PubMed Web of Science ®Google Scholar
• FrancoMATinCGreenbergHBCD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in miceJ Virol1997714165709094702
   PubMed Web of Science ®Google Scholar
• GAVI2001GAVI task force for R&D rotavirus vaccine agenda meetingGenevaWHO
   Google Scholar
• Georges-CourbotMCMongesJSiopathisMREvaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central AfricaRes Virol1991142405111663261
   PubMedGoogle Scholar
• GlassRILewJFGangarosaREEstimates of morbidity and mortality rates for diarrheal diseases in American childrenJ Pediatr1991118S27332007954
   PubMed Web of Science ®Google Scholar
• GlassRIParasharUDBreseeJSRotavirus vaccines: current prospects and future challengesLancet20063683233216860702
   PubMed Web of Science ®Google Scholar
• GorzigliaMLarraldeGKapikianAZAntigenic relationships among human rotaviruses as determined by outer capsid protein VP4Proc Natl Acad Sci U S A199087715591698292
   PubMed Web of Science ®Google Scholar
• HanlonPHanlonLMarshVTrial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infantsLancet19871134252884455
   PubMed Web of Science ®Google Scholar
• HoshinoYWyattRGGreenbergHBSerotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralizationJ Infect Dis19841496947026202807
   PubMed Web of Science ®Google Scholar
• Institute of MedicineProspects for immunizing against rotavirusNew Vaccine Development: Establishing Priorities: Diseases of Importance in Developing Countries1986Washington, D.CNational Academy Press303318
   Google Scholar
• KapikianAZClineWLKimHWAntigenic relationships among five reovirus-like (RVL) agents by complement fixation (CF) and development of new substitute CF antigens for the human RVL agent of infantile gastroenteritisProc Soc Exp Biol Med1976152535961589
   PubMed Web of Science ®Google Scholar
• KapikianAZFloresJHoshinoYRotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a “Jennerian” approach to vaccinationJ Infect Dis1986153815223009632
   PubMed Web of Science ®Google Scholar
• LanataCFBlackREdel AguilaRProtection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccineJ Infect Dis198915945292536789
   PubMed Web of Science ®Google Scholar
• MackowERShawRDMatsuiSMThe rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion regionProc Natl Acad Sci USA19888564592829198
   PubMed Web of Science ®Google Scholar
• MadoreHPChristyCPichicheroMField trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric GroupsJ Infect Dis1992166235431321858
   PubMed Web of Science ®Google Scholar
• MalherbeHHarwinRThe cytopathic effects of vervet monkey virusesS Afr Med J1963374071113932505
   PubMedGoogle Scholar
• MatsonDOO’RyanMLHerreraIFecal antibody responses to symptomatic and asymptomatic rotavirus infectionsJ Infect Dis1993167577838440929
   PubMed Web of Science ®Google Scholar
• MatthewsREThe classification and nomenclature of viruses. Summary of results of meetings of the International Committee on Taxonomy of Viruses in The Hague, September 1978Intervirology1979111335429146
   PubMed Web of Science ®Google Scholar
• McNealMMBaroneKSRaeMNEffector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in miceVirology1995214387978553539
   PubMed Web of Science ®Google Scholar
• McNealMMBroomeRLWardRLActive immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccinationVirology1994204642507941332
   PubMed Web of Science ®Google Scholar
• McNealMMRaeMNBeanJAAntibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particlesJ Virol19997375657310438846
   PubMed Web of Science ®Google Scholar
• McNealMMRaeMNConnerMEStimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21Virology1998243158669527925
   PubMed Web of Science ®Google Scholar
• McNealMMVanCottJLChoiAHCD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)J Virol200276560811752147
   PubMed Web of Science ®Google Scholar
• MebusCAUnderdahlNRRhodesMBCalf diarrhea (scours): Reproduced with a virus from a field outbreakUniv Nebraska Res Bull1969233116
   Google Scholar
• MoritaYTaniguchiKUrasawaTAnalysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variantsJ Gen Virol19886945182448418
   PubMed Web of Science ®Google Scholar
• MurphyBRMorensDMSimonsenLReappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusionsJ Infect Dis20031871301812696010
   PubMed Web of Science ®Google Scholar
• NguyenTVYuanLAzevedoMSHigh titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimenClin Vaccine Immunol2006134758516603615
   PubMed Web of Science ®Google Scholar
• O’NealCMClementsJDEstesMKRotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challengeJ Virol199872339039525668
   PubMed Web of Science ®Google Scholar
• O’NealCMCrawfordSEEstesMKRotavirus virus-like particles administered mucosally induce protective immunityJ Virol1997718707179343229
   PubMed Web of Science ®Google Scholar
• O’RyanMLMatsonDOEstesMKAnti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infectionsJ Infect Dis1994169504118158022
   PubMed Web of Science ®Google Scholar
• OffitPABoyleDBBothGWOuter capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, cytotoxic T lymphocytesVirology199118456381653488
   PubMed Web of Science ®Google Scholar
• OffitPADudzikKIRotavirus-specific cytotoxic T lymphocytes cross-react with target cells infected with different rotavirus serotypesJ Virol198862127312824841
   PubMed Web of Science ®Google Scholar
• OffitPADudzikKIRotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling miceJ Virol199064632581978734
   PubMed Web of Science ®Google Scholar
• Padilla-NoriegaLFioreLRennelsMBHumoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirusJ Clin Microbiol199230139271320626
   PubMed Web of Science ®Google Scholar
• PappenheimerAWEndersJFAn epidemic diarrheal disease of suckling mice. II Inclusions in the intestional epithelial cellsJ Exp Med194785417422
   PubMed Web of Science ®Google Scholar
• ParasharUDGibsonCJBresseJSRotavirus and severe childhood diarrheaEmerg Infect Dis200612304616494759
   PubMed Web of Science ®Google Scholar
• ParezNFourgeuxCMohamedARectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infectionJ Virol20068017526116439532
   PubMed Web of Science ®Google Scholar
• PhuaKBQuakSHLeeBWEvaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infantsJ Infect Dis2005192S6S1616088807
   PubMed Web of Science ®Google Scholar
• PrasadBVChiuWStructure of rotavirusCurr Top Microbiol Immunol19941859298050286
   PubMedGoogle Scholar
• ReadyKFMSabaraMIn vitro assembly of bovine rotavirus nucleocapsid proteinVirology1987157189983029958
   PubMed Web of Science ®Google Scholar
• Research priorities for diarroeal diseases vaccinesBull World Health Organ1991696676761664785
   PubMed Web of Science ®Google Scholar
• Ruiz-PalaciosGMPerez-SchaelIVelazquezFRSafety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritisN Engl J Med2006354112216394298
   PubMed Web of Science ®Google Scholar
• SaifLJBohlEHTheilKWRotavirus-like, calicivirus-like, and 23-nm virus-like particles associated with diarrhea in young pigsJ Clin Microbiol198012105116252238
   PubMed Web of Science ®Google Scholar
• SaifLJJiangBNongroup A rotaviruses of humans and animalsCurr Top Microbiol Immunol1994185339718050284
   PubMedGoogle Scholar
• SantoshamMLetsonGWWolffMA field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American populationJ Infect Dis199116348371995721
   PubMed Web of Science ®Google Scholar
• Schwartz-CornilIBenureauYGreenbergHHendricksonBACohenJHeterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulinsJ Virol200276168110712134016
   PubMed Web of Science ®Google Scholar
• ShawALRothnagelRChenDThree-dimensional visualization of the rotavirus hemagglutinin structureCell1993746937018395350
   PubMed Web of Science ®Google Scholar
• SmileyKLMcNealMMBasuMAssociation of IFNγ and IL-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G)J Virol2007813740817251301
   PubMed Web of Science ®Google Scholar
• SnodgrassDRHoshinoYFitzgeraldTAIdentification of four VP4 serological types (P serotypes) of bovine rotavirus using viral reassortantsJ Gen Virol1992732319251328488
   PubMed Web of Science ®Google Scholar
• TaniguchiKMaloyWLNishikawaKIdentification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirusJ Virol198862242162453680
   PubMed Web of Science ®Google Scholar
• ToTLWardLAYuanLSerum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of diseaseJ Gen Virol1998792661729820141
   PubMed Web of Science ®Google Scholar
• TreanorJJClarkHFPichicheroMEvaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infantsPediatr Infect Dis J19951430177603812
   PubMed Web of Science ®Google Scholar
• VanCottJLPradaAEMcNealMMMice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesJ Virol20068049496116641286
   PubMed Web of Science ®Google Scholar
• VelazquezFRMatsonDOCalvaJJRotavirus infections in infants as protection against subsequent infectionsN Engl J Med1996335102288793926
   PubMed Web of Science ®Google Scholar
• VelazquezFRMatsonDOGuerreroMLSerum antibody as a marker of protection against natural rotavirus infection and diseaseJ Infect Dis20001821602911069230
   PubMed Web of Science ®Google Scholar
• VesikariTIsolauriEDelemAClinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemicJ Pediatr1985107189943894608
   PubMed Web of Science ®Google Scholar
• VesikariTIsolauriEDelemAImmunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young childrenLancet19832807116137646
   PubMed Web of Science ®Google Scholar
• VesikariTKarvonenAKorhonenTSafety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infantsVaccine20042228364215246619
   PubMed Web of Science ®Google Scholar
• VesikariTKarvonenAKorhonenT2006Abstract of 24th Annual Meeting of the European Society for Pediatric Infectious DiseasesBasel, Switzerland
   Google Scholar
• VesikariTKarvonenAPuustinenLEfficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infantsPediatr Infect Dis J2004239374315602194
   PubMed Web of Science ®Google Scholar
• VesikariTKarvonenAVMajuriJSafety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish childrenJ Infect Dis2006194370616826486
   PubMed Web of Science ®Google Scholar
• VesikariTMatsonDODennehyPSafety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccineN Engl J Med2006354233316394299
   PubMed Web of Science ®Google Scholar
• VesikariTRautanenTVarisTRhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of ageAm J Dis Child199014428592154925
   PubMedGoogle Scholar
• WardRLBernsteinDIShuklaREffects of antibody to rotavirus on protection of adults challenged with a human rotavirusJ Infect Dis198915979882535868
   PubMed Web of Science ®Google Scholar
• WardRLKnowltonDRSchiffGMRelative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirusJ Virol198862154393357205
   PubMed Web of Science ®Google Scholar
• WardRLMcNealMMSanderDSImmunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young childrenJ Virol19936746488416378
   PubMed Web of Science ®Google Scholar
• WardRLMcNealMMSheridanJFEvidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibodyVirology199218857661314467
   PubMed Web of Science ®Google Scholar
• WoodeGNZhengSRosenBIProtection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responsesJ Clin Microbiol198725105283036908
   PubMed Web of Science ®Google Scholar
• WyattRGGreenbergHBJamesWDDefinition of human rotavirus serotypes by plaque reduction assayInfect Immun19823711056286487
   PubMed Web of Science ®Google Scholar
• WyattRGKalicaARMebusCAPollardMReovirus-like agents (rotaviruses) associated with diarrheal illness in animals and manPerspectives in Virology1978New YorkRaven Press121145
   Google Scholar
• YeagerMBerrimanJABakerTSBellamyARThree-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysisEmbo J199413101188131735
   PubMed Web of Science ®Google Scholar
• YoderJDDormitzerPRAlternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangementEmbo J20062515596816511559
   PubMed Web of Science ®Google Scholar
• YuanLGeyerAHodginsDCIntranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigsJ Virol20007488435310982326
   PubMed Web of Science ®Google Scholar
• YuanLSaifLJInduction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a modelVet Immunol Immunopathol2002871476012072229
   PubMed Web of Science ®Google Scholar